P390 Re-introduction of infliximab after consecutive failure of infliximab and adalimumab is beneficial in refractory Crohn's disease

Saved in:
Bibliographic Details
Published inJournal of Crohn's and colitis Vol. 7; pp. S165 - S166
Main Authors Brandse, J.F., Peters, C.P., Eshuis, E.J., Lowenberg, M., Ponsioen, C.Y., van den Brink, G.R., D'Haens, G.R.A.M.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.02.2013
Online AccessGet full text

Cover

More Information
ISSN:1873-9946
1876-4479
DOI:10.1016/S1873-9946(13)60411-0